eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content
H. Duan, S. Zhang, Y. Zarai, R. Oellinger, Y. Wu, L. Sun, C. Hu, G. Tian, R. Rad, Y. Cheng, T. Tuller, D. A. Wolf
The paper identifies eIF3k as a regulator of ribosome content in cancer by showing its depletion increases global translation and stress resistance through repression of RPS15A synthesis.
The EMBO Journal · May 8, 2023Peer-reviewedCell Biology